Palomid 529 (P529): Advancing PI3K/Akt/mTOR Inhibition in Dr
2026-05-12
Explore how Palomid 529 (P529) enables advanced cancer research through dual mTORC1/mTORC2 inhibition and novel application in drug-resistant models. This article delivers a unique, evidence-driven perspective on assay design and translational potential.
Quantitative In Vitro Metrics Improve Cancer Drug Evaluation
2026-05-11
Schwartz’s dissertation introduces refined in vitro metrics that distinguish cell proliferation arrest from cell death, revealing nuanced drug responses in cancer research. This methodological advance supports more precise evaluation of anticancer agents and underpins rational experimental design.
Plerixafor (AMD3100): Enhancing Cancer and Stem Cell Workflo
2026-05-11
Plerixafor (AMD3100) empowers researchers to dissect the CXCR4/CXCL12 axis, driving robust cancer metastasis inhibition and efficient hematopoietic stem cell mobilization. This guide reveals evidence-backed workflows, troubleshooting strategies, and practical protocol parameters to maximize research impact.
Rapamycin (Sirolimus): Precision mTOR Inhibition in Research
2026-05-10
Rapamycin (Sirolimus) enables robust, nanomolar-range inhibition of mTOR signaling, empowering reproducible studies in cancer, immunology, and mitochondrial disease. This guide delivers actionable protocols, experimental troubleshooting, and strategic insights grounded in leading-edge reference research and APExBIO’s gold-standard formulation.
Phillygenin Modulates Inflammation in Diabetic Nephropathy M
2026-05-09
This study demonstrates that phillygenin, a Forsythia-derived compound, alleviates diabetic nephropathy by regulating TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling in cellular and mouse models. The findings clarify key molecular pathways driving inflammation and apoptosis in diabetic kidney injury, informing future therapeutic development.
Deep Learning Reveals Cardiotoxicity in iPSC-CMs Screens
2026-05-09
Grafton et al. demonstrate a scalable deep learning approach to identify cardiotoxic compounds using high-content imaging of iPSC-derived cardiomyocytes. This study sets a new benchmark for early detection of drug-induced cardiac liabilities, supporting more predictive preclinical screening pipelines.
MRT68921 ULK1/2 Inhibitor: Decoding Autophagy-Lipid Metaboli
2026-05-08
Discover how MRT68921, a potent ULK1 kinase inhibitor, enables nuanced investigation of autophagy and lipid metabolism in preclinical research. This article uniquely bridges molecular inhibition with practical assay decisions, leveraging new lipidomics insights.
CK2α–VP2 Interaction is Essential for CIAV Replication
2026-05-07
This study uncovers the molecular mechanism by which chicken infectious anemia virus (CIAV) exploits host CK2α kinase to stabilize its VP2 protein and promote viral replication. Targeting the CK2α–VP2 interface, either genetically or with kinase inhibitors, markedly suppresses viral replication, identifying CK2α as a promising host-directed antiviral target.
Fucoidan (C4038): Apoptosis Pathways and Assay Optimization
2026-05-07
Discover how Fucoidan, a potent sulfated α-L-fucan, orchestrates apoptosis and immune modulation via distinct signaling pathways. This article delivers fresh, in-depth assay guidance and practical insights beyond translational and systems-level overviews.
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine i
2026-05-06
Unlock the full potential of 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine as a selective α2-adrenergic receptor agonist for immune modulation and recurrence studies. This guide delivers actionable workflows, troubleshooting strategies, and protocol enhancements for translational research in osteosarcoma and advanced receptor signaling applications.
Bovine Insulin: Precision Growth Factor for Cell Culture Suc
2026-05-06
Bovine insulin from APExBIO is a gold-standard growth factor supplement, empowering consistent cell proliferation and robust metabolic assays. This article reveals optimized workflows, troubleshooting strategies, and evidence-based advantages, connecting recent mechanistic research to practical lab use.
S-Adenosylhomocysteine: Protocols, Innovations, and Troubles
2026-05-05
S-Adenosylhomocysteine (SAH) from APExBIO empowers researchers to precisely modulate methylation dynamics, making it indispensable for studies in methyltransferase inhibition, neural differentiation, and cystathionine β-synthase deficiency. This guide delivers actionable protocols, advanced applications, and troubleshooting strategies for maximizing assay fidelity and reproducibility.
Olsalazine Sodium: Mesalamine Dimer in Inflammation & Cancer
2026-05-05
Olsalazine Sodium is a mesalamine dimer with high water solubility and potent anti-inflammatory activity via LTB4 chemotaxis inhibition. It is widely applied in colorectal cancer tumor models for its apoptosis-inducing and proliferation-inhibiting effects, with robust evidence supporting its use in research workflows.
Rosiglitazone (Brl-49653): Precision Tools for Adipocyte Lin
2026-05-04
Explore how Rosiglitazone (Brl-49653), a potent PPARγ agonist, is reshaping experimental strategies in adipocyte lineage tracing and metabolic pathway engineering. This article uniquely bridges technical protocols with recent mechanistic insights, offering new depth for type II diabetes and metabolic disease research.
Redefining Signal Network Purification: The Role of HyperTra
2026-05-04
This thought-leadership article explores how the HyperTrap Heparin HP Column, powered by HyperChrom Heparin HP Agarose, unlocks new precision in isolating critical regulatory proteins for translational research. Building from recent advances in breast cancer stem cell signaling, we provide strategic guidance for researchers aiming to dissect complex axes like CCR7–Notch1, and position the column at the forefront of high-impact mechanistic discovery.
458 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page